Publicacións en colaboración con investigadores/as de Clínica Universitaria de Navarra (9)

2020

  1. Author Correction: MicroRNA-19b is a potential biomarker of increased myocardial collagen cross-linking in patients with aortic stenosis and heart failure (Scientific Reports, (2017), 7, 1, (40696), 10.1038/srep40696)

    Scientific Reports

2017

  1. Hypertensive Heart Disease

    Encyclopedia of Cardiovascular Research and Medicine (Elsevier), pp. 517-526

  2. MicroRNA-19b is a potential biomarker of increased myocardial collagen cross-linking in patients with aortic stenosis and heart failure

    Scientific Reports, Vol. 7

2015

  1. Circulating biomarkers of myocardial fibrosis: The need for a reappraisal

    Journal of the American College of Cardiology, Vol. 65, Núm. 22, pp. 2449-2456

2014

  1. Association of Phagocytic NADPH Oxidase Activity With Hypertensive Heart Disease: A Role for Cardiotrophin-1?

    Hypertension, Vol. 63, Núm. 3, pp. 468-474

  2. microRNA-122 down-regulation may play a role in severe myocardial fibrosis in human aortic stenosis through TGF-β1 up-regulation

    Clinical Science, Vol. 126, Núm. 7, pp. 497-506

2007

  1. A novel CYBA variant, the -675A/T polymorphism, is associated with essential hypertension

    Journal of Hypertension, Vol. 25, Núm. 8, pp. 1620-1626

2004

  1. Estrés oxidativo en la hipertensión: De los SNPs al fenotipo clínico

    Nefrologia, Vol. 24, Núm. SUPPL.4, pp. 25-28

2003

  1. Papel del anión superóxido en la fisiopatología de las enfermedades vasculares

    Nefrologia, Vol. 23, Núm. SUPPL.4, pp. 13-20